Erste Group Bank Issues Negative Forecast for Roche Earnings

Roche Holding AG (OTCMKTS:RHHBY) – Erste Group Bank decreased their FY2026 earnings per share estimates for shares of Roche in a research note issued to investors on Thursday, June 25th. Erste Group Bank analyst H. Engel now expects that the company will earn $3.12 per share for the year, down from their prior estimate of $3.18. The consensus estimate for Roche’s current full-year earnings is $3.29 per share.

RHHBY has been the topic of a number of other research reports. Argus raised shares of Roche from a “hold” rating to a “buy” rating in a research note on Monday, April 6th. Morgan Stanley raised shares of Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 target price for the company in a research note on Friday, April 24th. Five investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, Roche currently has a consensus rating of “Hold” and a consensus target price of $51.50.

Roche Price Performance

Shares of RHHBY opened at $50.32 on Thursday. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.38 and a quick ratio of 1.12. Roche has a 12 month low of $37.51 and a 12 month high of $60.85. The stock’s 50 day moving average is $51.19 and its two-hundred day moving average is $52.65.

Institutional Trading of Roche

Large investors have recently made changes to their positions in the company. Confluence Investment Management LLC lifted its holdings in Roche by 1.2% in the 2nd quarter. Confluence Investment Management LLC now owns 20,925 shares of the company’s stock valued at $1,074,000 after purchasing an additional 258 shares in the last quarter. McIlrath & Eck LLC acquired a new position in Roche during the first quarter worth $39,000. Opal Capital LLC purchased a new stake in Roche in the 1st quarter valued at $4,448,000. PNC Financial Services Group Inc. increased its stake in shares of Roche by 5.4% in the 1st quarter. PNC Financial Services Group Inc. now owns 23,456 shares of the company’s stock worth $1,166,000 after acquiring an additional 1,201 shares during the last quarter. Finally, S&CO Inc. raised its holdings in shares of Roche by 163.0% during the 1st quarter. S&CO Inc. now owns 140,551 shares of the company’s stock worth $6,880,000 after acquiring an additional 87,107 shares during the period.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.